tulathromycin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| antibiotics, produced by Streptomyces strains | 5640 | 217500-96-4 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
|
Drug dosage:
None
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| MeSH PA | D000900 | Anti-Bacterial Agents |
| MeSH PA | D000890 | Anti-Infective Agents |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
| Species | Use | Relation |
|---|---|---|
| Cattle | Bovine foot rot (interdigital necrobacillosis) associated with Fusobacterium necrophorum | Indication |
| Cattle | Infectious bovine keratoconjunctivitis associated with Moraxella bovis | Indication |
| Cattle | Bovine respiratory disease (BRD) associated with Mannheimia haemolytica | Indication |
| Cattle | Respiratory disease with high risk of developing BRD associated with M haemolytica | Indication |
| Cattle | Bovine foot rot (interdigital necrobacillosis) associated with Porphyromonas levii | Indication |
| Cattle | Bovine respiratory disease (BRD) associated with Pasteurella multocida | Indication |
| Cattle | Bovine respiratory disease (BRD) associated with Histophilus somni | Indication |
| Cattle | Bovine respiratory disease (BRD) associated with Mycoplasma bovis | Indication |
| Cattle | Respiratory disease with high risk of developing BRD associated with Pasteurella multocida | Indication |
| Cattle | Respiratory disease with high risk of developing BRD associated with H somni | Indication |
| Cattle | Respiratory disease with high risk of developing BRD associated with M bovis | Indication |
| Swine | Swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae | Indication |
| Swine | To control SRD associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, and M hyopneumoniae | Indication |
| Swine | Swine respiratory disease (SRD) associated with Pasteurella multocida | Indication |
| Swine | Swine respiratory disease (SRD) associated with Bordetella bronchiseptica | Indication |
| Swine | Swine respiratory disease (SRD) associated with H parasuis | Indication |
| Swine | Swine respiratory disease (SRD) associated with Mycoplasma hyopneumoniae | Indication |
🐶 Veterinary products
| Product | Applicant | Ingredients |
|---|---|---|
| Draxxin | Zoetis Inc. | 1 |
| Draxxin 25 Injectable Solution | Zoetis Inc. | 1 |
| Draxxin KP | Zoetis Inc. | 2 |
| MACROSYN | Bimeda Animal Health Limited | 1 |
| Increxxa 25 | Elanco US Inc. | 1 |
| Increxxa | Elanco US Inc. | 1 |
| Tulissin 25 | Virbac AH Inc. | 1 |
| Tulissin 100 | Virbac AH Inc. | 1 |
| TULAVEN 100 | Ceva Sante Animale | 1 |
| TULAVEN 25 | Ceva Sante Animale | 1 |
| AROVYN | Intervet Inc. | 1 |
| Tulieve | Norbrook Laboratories, Ltd. | 1 |
Acid dissociation constants calculated using MoKa v3.0.0
None
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| C485204 | MESH_SUPPLEMENTAL_RECORD_UI |
| DB11474 | DRUGBANK_ID |
| C1451406 | UMLSCUI |
| 8236 | INN_ID |
| 725635000 | SNOMEDCT_US |
| D06258 | KEGG_DRUG |
| 9832301 | PUBCHEM_CID |
| 1309314 | RXNORM |
| Q839I13422 | UNII |
Pharmaceutical products:
None